A new U.S. study published in European Heart Journal – Digital Health shows that an AI-enabled digital stethoscope can more than double the detection of moderate to severe valvular heart disease during routine clinical exams compared to a traditional stethoscope. The findings highlight the potential of AI to improve early diagnosis of a condition that is common in older adults but often goes undetected until it becomes severe.
The prospective study evaluated 357 patients aged 50 and older across three primary care settings, with participants assessed using both a conventional stethoscope and an AI-assisted digital device. The results showed a significant improvement in diagnostic performance: the AI-enabled stethoscope achieved 92.3% sensitivity, compared to 46.2% with traditional auscultation. The tool works by capturing high-fidelity heart sounds and applying machine learning algorithms trained to detect acoustic patterns associated with valvular abnormalities.
Valvular heart disease affects more than half of adults over 65, yet symptoms are often subtle or absent, leading to delayed diagnosis and increased risk of complications such as heart failure, arrhythmia, and hospitalization. By improving detection at the point of care, the AI-enabled device could help clinicians identify at-risk patients earlier and refer them more quickly for confirmatory testing, such as echocardiography, potentially improving outcomes and reducing healthcare costs.
Researchers emphasized that the technology is designed to augment—not replace—clinical judgment, providing an additional layer of analysis that supports more consistent and confident assessments. The study also noted increased patient engagement during AI-assisted exams, as patients could see and hear the data being analyzed. While the AI device showed slightly lower specificity, raising the possibility of more false positives, the authors suggest this trade-off may be acceptable given the benefits of earlier detection. Further studies are planned to validate performance across broader populations and clinical settings.
Click here to read the original news story.